• No results found

From single-drug pharmacokinetics and pharmacodynamics to multi-drug interaction modeling: using population-based modeling to increase accuracy of anesthetic drug titration: "Surfing the wave"

N/A
N/A
Protected

Academic year: 2021

Share "From single-drug pharmacokinetics and pharmacodynamics to multi-drug interaction modeling: using population-based modeling to increase accuracy of anesthetic drug titration: "Surfing the wave""

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

From single-drug pharmacokinetics and pharmacodynamics to multi-drug interaction

modeling: using population-based modeling to increase accuracy of anesthetic drug titration

Hannivoort, Laura Naomi

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Hannivoort, L. N. (2018). From single-drug pharmacokinetics and pharmacodynamics to multi-drug

interaction modeling: using population-based modeling to increase accuracy of anesthetic drug titration:

"Surfing the wave". Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen behorend bij het proefschrift

From single-drug pharmacokinetics and pharmacodynamics to multi-drug interaction modeling: using population-based modeling to increase accuracy of anesthetic drug titration

Laura N. Hannivoort 26 juni 2018

1) All models are wrong, but some are useful - George Box

2) As yet unidentified factors within an individual changing over time can have a greater influence on pharmacokinetic model parameters than differences between individuals - This thesis 3) Stimulation of a person under dexmedetomidine sedation increases the BIS acutely, after which

the person ‘falls back to sleep’, in 1 to 35 minutes - This thesis

4) Background noise makes a person under dexmedetomidine sedation more susceptible to the sedative effects when assessed by MOAA/S score - This thesis

5) The two mean arterial blood pressure effect-site compartments in dexmedetomidine PKPD explain both the initial fast infusion hypertension and the high concentration hypertension, and correspond with the different physiologic substrates for receptor activation for hypo- and hypertension - This thesis

6) Deep sedation with dexmedetomidine corresponds well with normalization of the mean arterial blood pressure – the phase between hypotension at low concentrations and hypertension at high concentrations – but does induce bradycardia - This thesis

7) Beware the post-dexmedetomidine hypotension! - This thesis

8) Although opioids are known to have a large effect on probability of tolerance of noxious stimuli, they only have minimal influence on EEG-derived measurements of hypnotic drug effect - This thesis

9) Interaction model-based calculated parameters (PTOL, NSRI) are better predictors of tolerance of

noxious stimuli than current measurements of components of anesthesia - This thesis 10) Science may be described as the art of oversimplification - Karl Popper

11) There is no delusion more damaging than to get the idea in your head that you understand the

Referenties

GERELATEERDE DOCUMENTEN

enzymes metabolize about 40% of drugs used in daily clinical practice, the interaction between drug and variant CYP2C9, CYP2C19, and CYP2D6 alleles (drug-gene interaction/DGI)

Outcome measures were defined as frequency of potential CYP2D6/2C19/2C9 mediated DDIs as well as the levels of agreement between information from the self-reported Lifelines

Based on the two main knowledge-bases of DDI alert systems (G-Standaard and Pharmabase), incidences were divided between signalled (metoprolol-fluoxetine/paroxetine)

We found that the risk of discontinuation and dose adjustment of metoprolol in the metoprolol-paroxetine/ fluoxetine combination is not significantly different from

Experimental studies reported that paroxetine increased the AUC of metoprolol three to five times, and significantly decreased systolic blood pressure and heart rate of

Omeprazole and lansoprazole produced a greater magnitude of interactions with fluvoxamine than rabeprazole for all genotypes, because rabeprazole only involves CYP2C19 in

No participants with CYP2C19 UM and CYP3A4 NM/IM combination experienced drug switching and/or dose reduction and no significant association with early discontinuation as well as

We further reviewed systematically the impact of polymorphisms on three main drug metabolic enzymes (CYP2D6, CYP2C19, and CYP2C9) mediated DDIs and drug-drug-gene-interactions